Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2017
At a glance
- Drugs ANB 020 (Primary)
- Indications Asthma; Peanut hypersensitivity
- Focus Proof of concept; Therapeutic Use
- Sponsors AnaptysBio
- 04 Mar 2017 According to AnaptysBio media release, top line data from this study are anticipated during the second half of 2017.
- 03 Jan 2017 Status changed from not yet recruiting to recruiting.
- 13 Dec 2016 According to AnaptysBio media release, US FDA has cleared the investigational new drug application (IND) to initiate this trial.